Prelude Therapeutics, Inc. (PRLD)
5.56
+0.09
(+1.65%)
USD |
NASDAQ |
Aug 31, 15:07
Prelude Therapeutics Total Assets (Quarterly) : 189.36M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 189.36M |
| March 31, 2026 | 119.64M |
| December 31, 2025 | 141.32M |
| September 30, 2025 | 94.76M |
| June 30, 2025 | 114.92M |
| March 31, 2025 | 141.26M |
| December 31, 2024 | 175.52M |
| September 30, 2024 | 197.22M |
| June 30, 2024 | 224.29M |
| March 31, 2024 | 247.11M |
| December 31, 2023 | 277.66M |
| September 30, 2023 | 258.51M |
| June 30, 2023 | 280.61M |
| March 31, 2023 | 198.32M |
| Date | Value |
|---|---|
| December 31, 2022 | 220.50M |
| September 30, 2022 | 242.33M |
| June 30, 2022 | 259.06M |
| March 31, 2022 | 280.67M |
| December 31, 2021 | 305.10M |
| September 30, 2021 | 331.22M |
| June 30, 2021 | 349.58M |
| March 31, 2021 | 369.83M |
| December 31, 2020 | 223.59M |
| September 30, 2020 | 239.68M |
| June 30, 2020 | 32.75M |
| March 31, 2020 | |
| December 31, 2019 | 21.87M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Intellia Therapeutics, Inc. | 857.16M |
| Twist Bioscience Corp. | 672.44M |
| Beam Therapeutics, Inc. | 1.386B |
| Revolution Medicines, Inc. | 4.323B |
| Sana Biotechnology, Inc. | 431.52M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 55.63M |
| Shareholders Equity (Quarterly) | 133.73M |
| Debt to Equity Ratio | 0.132 |
| Current Ratio | 4.072 |
| Net Debt Paydown Yield | 0.01% |